TNM staging system
TNM staging system is a globally recognized system for classifying the extent of spread of cancer. It is a tool used by oncologists to determine the prognosis and treatment plan for individuals diagnosed with cancer. The system is maintained by the Union for International Cancer Control (UICC).
Overview[edit]
The TNM staging system is based on the size and extent of the tumor (T), the number of nearby lymph nodes that have cancer (N), and whether the cancer has spread, or metastasized, to other parts of the body (M). Each of these categories is further divided into subcategories to provide a detailed description of the cancer's progression.
Components[edit]
Tumor (T)[edit]
The T in TNM stands for tumor. The size and extent of the primary tumor is classified on a scale from TX (tumor cannot be measured) to T4 (tumor has grown into nearby tissues or organs).
Nodes (N)[edit]
The N in TNM stands for nodes. This refers to whether the cancer has spread to nearby lymph nodes. It is classified on a scale from NX (cancer in nearby nodes cannot be measured) to N3 (cancer has spread to many nearby nodes).
Metastasis (M)[edit]
The M in TNM stands for metastasis. This refers to whether the cancer has spread to other parts of the body. It is classified as either M0 (no distant spread) or M1 (cancer has spread to distant parts of the body).
Usage[edit]
The TNM staging system is used by medical professionals worldwide to classify the extent of cancer spread. It helps in determining the prognosis and in planning the treatment. It also allows for the comparison of individual patient outcomes, both within and across institutions.
See also[edit]
TNM staging system[edit]
-
Diagram showing the T stages of bladder cancer
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
